Media Pack
News

Current Edition

Volume 16 Issue 1
 
news

Bioclinica Launches Clinical Adjudication Led by Experienced Medical Specialists and Researchers for Enhanced Safety & Efficacy in Clinical Trials

Bioclinica®, the world-leading provider of technology-enabled solutions for clinical research, today announces the launch of Bioclinica Clinical Adjudication, a trans...
30 November 2017 news clinical | e-health
Continue Reading →
news

WIRB-Copernicus Group Partners with Veeva Systems Inc to improve the speed and accuracy of institutional review board (IRB) document transfer

WIRB-Copernicus Group® (WCG™), the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced that...
29 November 2017 news clinical | document
Continue Reading →
news

SOTIO Broadens Its Phase II Clinical Trial Program in Ovarian Cancer

SOTIO, a biotechnology company owned by the PPF Group, today announced the enrollment of the first patient to a Phase II study testing DCVAC/OvCa in combination with ...
29 November 2017 news cancer | chemotherapy
Continue Reading →
news

New study results support use of DiviTum ® for evaluation of pancreatic cancer

In collaboration with University of Heidelberg, Germany, results from a clinical study of pancreatic cancer are published in the Pancreas scientific journal. The res...
22 November 2017 news cancer | clinical
Continue Reading →
news

Arcus Biosciences secures funding to advance clinical programs for AB928

Clinical-stage biotechnology company Arcus Biosciences has completed a $107m series C financing, bringing the total equity capital to around $227m. The proceeds from ...
22 November 2017 news biotechnology | cancer
Continue Reading →
news

Clinical placebo study confirms medical evidence for the Antinitus patch as a treatment method for tinnitus

The results of a recent clinical placebo study indicates significant and statistically assured positive effects of the Antinitus patch for reducing discomfort from t...
15 November 2017 news clinical | development
Continue Reading →
news

Nanobiotix presented new clinical and pre-clinical data confirming NBTXR3’s significant potential role in Immuno-Oncology at SITC Annual Meeting

Nanobiotix, a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, recently presented positive clinical and preclinical data...
15 November 2017 news cancer | clinical
Continue Reading →
news

New Swedish study results at SABCS show DiviTum ® blood test reduces waiting times for evaluating breast cancer treatment

Results from a study of 142 women with newly diagnosed metastatic breast cancer will be presented by researchers from Lund University at the world’s biggest breast c...
15 November 2017 news biomarker | biopsy
Continue Reading →
news

Imcyse continues patient enrolment in its Phase 1b trial in type 1 diabetes

Imcyse, a biotechnology company developing active specific therapies for the treatment of severe chronic diseases, today announces that it began recruiting patients i...
15 November 2017 news clinical | diabetes
Continue Reading →
news

Fortuna Fix Announces Series B Financing, Adding Amgen Ventures and Macnguyen Family Office as Shareholders

Fortuna Fix, a private, clinical-stage Regenerative Medicine company is aiming to be the first to bring to the clinic a patient's own neural stem cells (autologous) p...
8 November 2017 news clinical | neurotrauma
Continue Reading →
 
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte